Respondents from large companies: n=61, from small/mid: n=89
Method of interview
Panel survey
Supplementary notes
The respondents are working for pharma, biopharma, or
biotech companies; they have drug development decision-making responsibility and
are director-level or above; they work in a role related to drug development; their companies have at least one compound in development; they are from the US/Canada, Europe, and Asia.
Original question: "For the areas in your company with which you are familiar, what percent of current clinical development work that is outsourced is accomplished via the following outsourcing models?"
Percentage points missing/exceeding 100 percent are probably due to rounding.
Citation formats
Outsourcing in clinical development among global biopharma companies by size 2025
According to a survey conducted in 2025, ** percent of surveyed biopharma executives stated that the full-service model is the preferred outsourcing model for their clinical development work. Meanwhile, ** percent of biopharma executives preferred a hybrid model for outsourcing.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Thermo Fisher (PPD). (February 17, 2026). Percentage of outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2025, by company size [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 01, 2026, from /statistics/1414480/biopharmaceutical-companies-outsourcing-models-by-company-size/
Thermo Fisher (PPD). "Percentage of outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2025, by company size." Chart. February 17, 2026. ÌÇÐÄÆƽâ°æ. Accessed August 01, 2026. /statistics/1414480/biopharmaceutical-companies-outsourcing-models-by-company-size/
Thermo Fisher (PPD). (2026). Percentage of outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2025, by company size. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 01, 2026. /statistics/1414480/biopharmaceutical-companies-outsourcing-models-by-company-size/
Thermo Fisher (PPD). "Percentage of Outsourcing Models in Clinical Development among Biopharmaceutical Companies Worldwide as of 2025, by Company Size." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 17 Feb 2026, /statistics/1414480/biopharmaceutical-companies-outsourcing-models-by-company-size/
Thermo Fisher (PPD), Percentage of outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2025, by company size ÌÇÐÄÆƽâ°æ, /statistics/1414480/biopharmaceutical-companies-outsourcing-models-by-company-size/ (last visited August 01, 2026)
Percentage of outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2025, by company size [Graph], Thermo Fisher (PPD), February 17, 2026. [Online]. Available: /statistics/1414480/biopharmaceutical-companies-outsourcing-models-by-company-size/
